Related Experiment Video
Updated: Apr 23, 2026

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Antifungal activity of topical microemulsion containing a thiophene derivative
Geovani Pereira Guimarães1, Mysrayn Yargo de Freitas Araújo Reis2, Dayanne Tomaz Casimiro da Silva2
1Programa de Pós-Graduação em Ciências Farmacêuticas Universidade Estadual da Paraíba Campina GrandePB Brazil Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, PB, Brazil.
Abstract:
Fungal infections have become a major problem of worldwide concern. Yeasts belonging to the Candida genus and the pathogenic fungus Cryptococcus neoformans are responsible for different clinical manifestations, especially in immunocompromised patients. Antifungal therapies are currently based on a few chemotherapeutic agents that have problems related to effectiveness and resistance profiles. Microemulsions are isotropic, thermodynamically stable transparent systems of oil, water and surfactant that can improve the solubilization of lipophilic drugs. Taking into account the need for more effective and less toxic drugs along with the potential of thiophene derivatives as inhibitors of pathogenic fungi growth, this study aimed to evaluate the antifungal activity of a thiophene derivative (5CN05) embedded in a microemulsion (ME). The minimum inhibitory concentration (MIC) was determined using the microdilution method using amphotericin B as a control. The formulations tested (ME- blank and ME-5CN05) showed physico-chemical properties that would allow their use by the topical route. 5CN05 as such exhibited moderate or weak antifungal activity against Candida species (MIC = 270-540 μg . mL(-1)) and good activity against C. neoformans (MIC = 17 μg . mL(-1)). Candida species were susceptible to ME-5CN05 (70-140 μg . mL(-1)), but C. neoformans was much more, presenting a MIC value of 2.2 μg . mL(-1). The results of this work proved promising for the pharmaceutical industry, because they suggest an alternative therapy against C. neoformans.
Insights
A novel thiophene derivative (5CN05) in a microemulsion (ME) formulation shows enhanced antifungal activity, particularly against Cryptococcus neoformans. This study suggests a promising alternative therapy for fungal infections, especially in immunocompromised individuals.
Area of Science:
- Mycology
- Pharmaceutical Sciences
- Drug Delivery Systems
Background:
- Fungal infections pose a significant global health challenge, particularly for immunocompromised patients, with existing antifungal treatments facing limitations in efficacy and resistance.
- Current antifungal therapies are limited, necessitating the development of novel agents with improved effectiveness and safety profiles.
- Microemulsions offer a stable drug delivery system for enhancing the solubility and efficacy of lipophilic compounds.
Purpose of the Study:
- To evaluate the antifungal activity of a thiophene derivative (5CN05) encapsulated within a microemulsion (ME) for potential topical application.
- To compare the efficacy of the 5CN05-loaded microemulsion against Candida species and Cryptococcus neoformans with the free compound and a standard antifungal agent.
- To explore the potential of microemulsion-based drug delivery systems for improving antifungal drug performance.
Main Methods:
- The antifungal activity was assessed using the microdilution method to determine the minimum inhibitory concentration (MIC).
- Physicochemical properties of the blank microemulsion (ME-blank) and the 5CN05-loaded microemulsion (ME-5CN05) were evaluated for topical suitability.
- Amphotericin B was used as a control antifungal agent for comparative analysis.
Main Results:
- The thiophene derivative 5CN05 demonstrated moderate to weak activity against Candida species (MIC = 270-540 μg/mL) but good activity against C. neoformans (MIC = 17 μg/mL).
- Encapsulation in microemulsions significantly enhanced the antifungal potency of 5CN05 against Candida species (MIC = 70-140 μg/mL).
- The ME-5CN05 formulation exhibited markedly improved activity against C. neoformans, with a MIC of 2.2 μg/mL, indicating a substantial increase in efficacy.
Conclusions:
- The microemulsion formulation significantly potentiates the antifungal activity of the thiophene derivative 5CN05, especially against Cryptococcus neoformans.
- The developed ME-5CN05 formulation shows promise as an effective and potentially less toxic alternative therapeutic strategy for treating C. neoformans infections.
- This study highlights the potential of microemulsions as a viable drug delivery system for developing novel antifungal agents for pharmaceutical applications.
Related Concept Videos
Antifungal Agents
Antimicrobial Effectiveness
Fungal Phylum Microsporidia
Anthelminthic Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Hand hygiene
Hand washing...

